Quarterly report pursuant to Section 13 or 15(d)

Accounts Receivable - Schedule of Accounts Receivable (Details)

v3.19.3.a.u2
Accounts Receivable - Schedule of Accounts Receivable (Details) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Accounts receivable, gross $ 40,553,779 $ 32,229,653
Less: Amount purchased by factor (1,017,769)
Less: Allowance for bad debts (2,392,159) (2,777,521)
Accounts receivable, net 4,908,594 3,811,749
Clinical Laboratory Operations [Member]    
Accounts receivable, gross 272,369 622,009
Less: Allowance for discounts (236,898) (573,584)
Hospitals Operations [Member]    
Accounts receivable, gross 40,295,551 31,607,644
Less: Allowance for discounts (31,998,359) (25,066,799)
Other [Member]    
Accounts receivable, gross $ (14,141)